Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Marek Gawel"'
Autor:
Gawel, Marek (AUTHOR)
Publikováno v:
Der Handel. 9/2/2021, Issue 4, p12-12. 1p.
Autor:
Krupp, Norbert (AUTHOR)
Publikováno v:
Allgemeine Hotel- und Gastronomie-Zeitung. 1/11/2020, Issue 1/2, p17-17. 1p.
Publikováno v:
2022 23rd International Radar Symposium (IRS).
Autor:
Maciej Wielgo, Damian Gromek, Piotr Samczynski, Krzysztof Stasiak, Karol Abratkiewicz, Marek Gawel
Publikováno v:
2021 CIE International Conference on Radar (Radar).
Autor:
William Pryse-Phillips, Michel Aubé, Peter Bailey, Werner J. Becker, Andre Bellavance, Marek Gawel, Rose Giammarco, Gordon Mackie, R. Allan Purdy, Gordon Robinson, Gary Shapero, Keith Wilson
Publikováno v:
Headache: The Journal of Head and Face Pain. 46:1480-1486
Background.—The buildup time of migraine headaches has not been well delineated in publications to date and we are aware of patients whose migraines last well over 72 hours. More concentration on these factors in the assessment of patients might le
Autor:
Paul E. Cooper, Marek Gawel, Jonathan P. Gladstone, Tamara Pringsheim, Irene Worthington, Werner J. Becker, Elizabeth Leroux, Esma Dilli, Michel Aube
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 40:S1-S3
Objectives:The primary objective of this guideline is to assist the practitioner in choosing an appropriate acute medication for an individual with migraine, based on current evidence in the medical literature and expert consensus. It is focused on p
Autor:
Janette Hughes, Marek Gawel, Andrew J. Dowson, Bruce R. Charlesworth, Nick Syrett, Graham Wilson
Publikováno v:
Headache Care. 1:261-266
Publikováno v:
Headache Care. 1:293-297
Autor:
Tamara Pringsheim, Marek Gawel
Publikováno v:
Current Pain and Headache Reports. 6:140-146
The triptans have provided a major advance in the treatment of the pain and disability associated with migraine headache. With seven triptans in use or in clinical development, the clinician is faced with the decision of which triptan to prescribe to
Publikováno v:
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 28:30-41
Objective:A systematic review of the literature was undertaken, to consolidate evidence concerning the efficacy and safety of triptans currently available in Canada (sumatriptan, rizatriptan, naratriptan, zolmitriptan), and to provide guidelines for